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Pleuropulmonary blastoma (PPB) is a rare malignant pulmonary neoplasm observed during childhood.
PPB is classiﬁed into three types according to the pathological ﬁndings: type I (purely cystic), type II
(cystic and solid) and type III (purely solid). Only three cases of PPB diagnosed during the prenatal period
have been reported in the previous literature, all of which involved PPB type I. We herein report the case
of a female infant with PPB type II detected on maternal ultrasonography. The patient underwent surgical
resection with adjuvant postoperative chemotherapy in the neonatal period due to persistent respiratory
instability. According to the previous literature, the prognosis of type II and III disease is less favorable
than that of type I. The present patient achieved 11 years of disease-free-survival. To our best knowledge,
this is the ﬁrst report of PPB type II diagnosed during the prenatal period.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Pleuropulmonary blastoma (PPB) is a rare, progressive and
aggressive malignant intrathoracic tumor observed during child-
hood [1,2]. Making a deﬁnitive diagnosis of PPB based on clinical
manifestations and imaging studies can be difﬁcult due to the wide
spectrum of differential diagnoses, including congenital cystic
adenomatoid malformation (CCAM) [3]. However, delayed diag-
nosis and treatment for PPB are sometimes associated with fatal
outcomes. Only three prenatally diagnosed cases have been re-
ported in the previous literature: the pathological diagnosis was
type I in each case. We herein report the ﬁrst case of PPB type II
detected during the prenatal period.
1. Case report
A female was born at 38 weeks of gestation via induced
vaginal delivery due to tumor compression of the mediastinum.
A left-sided lung mass had been detected at 37 weeks of gesta-
tion on prenatal ultrasound testing. Immediately after birth,
respiratory distress was detected and the patient requiredBY-NC-ND license (http://
þ81 942 31 7705.
u.ac.jp (N. Higashidate).
Published by Elsevier Inc. All rightimmediate intubation and mechanical ventilation. A chest X-ray
showed a giant mass occupying the left thoracic cavity, with the
mediastinum shifted to the right side (Fig. 1). Contrast-enhanced
computed tomography (CT) revealed a tumor measuring
6  6  3 cm in size that was enhanced non-uniformly. Magnetic
resonance imaging (MRI) showed a mixture of cystic and solid
components, and intratumoral hemorrhage was suspected
(Fig. 2). Several antibiotics were administered; however, the
treatment was ineffective. The initial diagnosis was CCAM type 2
and twenty-two days after birth, thoracotomy was performed.
The baby was placed in the right lateral decubitus position, and
the skin incision was made at the level of the seventh costal
cartilage between the parasternal line and the posterior axillary
line. A tumor measuring 6 cm-in size occupied the dorsocaudal
region of the left thoracic cavity, and the left lower lobe was
shifted ventrally. The tumor originated from the pleura sur-
rounding the hilum of pulmonis and connected with the pleura
via the still, including the feeding artery. Removal of the tumor
was undertaken with ligation of the still. The exact tumor size
was 6.7  6.3  3.4 cm, with a weight of 86 g. Histopathologi-
cally, the tumor was primarily composed of diffuse proliferation
of round to oval cells with hyperchromatic nuclei, prominent
nucleoli and scant cytoplasm, accompanied by mild chronic
active inﬂammatory inﬁltration. Mitotic ﬁgures were occasionallys reserved.
Fig. 1. Chest X ray at birth showed a giant mass occupying the left thoracic cavity.
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columnar epithelium were also observed in the low-power ﬁeld.
Immunohistochemically, the tumor cells were positive for
vimentin, cytokeratin, lysosome and a-SMA. These ﬁndings were
compatible with a diagnosis of PPB type II (Fig. 3). The patientFig. 2. (A) The tumor occupied almost all of the left lung ﬁeld. (B) Contrast-enhanced CT sho
to the right. (C) MRI T1WI showed a calciﬁed component in the tumor. (D) MRI T2STIR sugrecovered uneventfully during the perioperative period. She
subsequently received VAC chemotherapy (Vincristine, Actino-
mycin and Cyclophosphamide) as adjuvant chemotherapy and
has achieved a disease-free survival of 11 years as of today.2. Discussion
PPB was ﬁrst described in 1988 as a malignant immature tumor
of the chest in children arising from the lung mesenchyme [1]. The
pathological ﬁndings of PPB are similar to those of adult-type
pulmonary blastoma in that the lesions are composed of blastoma
and stroma, although PPB has no malignant epithelial component.
Priest et al. classiﬁed 50 cases of PPB into three groups according to
the histological features: type I (pure cystic), type II (cystic and
solid) and type III (purely solid) [2]. The mean age at presentation of
type I, II and III was 10, 34 and 44 months, respectively. Type I was
found to be associated with a lower rate of recurrence than types II
and III and included no metastatic lesions. In that report, the ﬁve-
year survival rates of type I and the others were reported to be 83%
and 42%, respectively. These ﬁndings suggest that the cystic type
PPB tends to present earlier with a more favorable prognosis than
solid-type PPB.
Interestingly, transitional cases from PPB type I to type II or III
have been reported. In some cases, although the biopsy specimen
showed type I features, the resected tumor was diagnosed as type II
or III. In other cases, although the primary tumor was diagnosed as
type I disease, the recurrent lesion was diagnosed as type III [4,5].
These ﬁndings suggest that some PPB cases exhibit characteristics
of progression from type I to type II or III and that the prognosis
deteriorates as the lesions transition to the solid type.wed a non-uniformly enhanced cystic and solid mass, with shifting of the mediastinum
gested hemorrhage in the tumor.
Fig. 3. (A) Cystic spaces lined with cuboidal and columnar epitheliumwere observed in
the low-power ﬁeld (H&E stain 100). (B) The tumor was primarily composed of diffuse
proliferation of round to oval cells with hyperchromatic nuclei, prominent nucleoli and
scant cytoplasm, accompanied by mild chronic active inﬂammatory inﬁltration. Mitotic
ﬁgures were occasionally seen in the tumor cells (H&E stain  400).
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cause of PPB. For example, heterozygous germline mutations in the
DICER1 locus to 14q were identiﬁed in affected members in 11
families in 2009 [6]. The DICER1 mutation results in the loss of
function of DICER1, which regulates stem cell maintenance,
organogenesis and oncogenesis. The functional loss of DICER1 in
developing mouse lungs leads to cystic airway disease, disruption
of branching morphogenesis and mesenchymal expansion, resem-
bling the early stage of PPB.
PPB is sometimes accompanied by other tumors, not only in the
same patient, but also other family members [7]. Recently, theTable 1
The characteristics of prenatally diagnosed PPB cases.
Patient Gestational
age at
diagnosis
Modality Respiration
before
operation
Preoperative
diagnosis
Age at
operation
Tum
Our case 37 weeks US Distress, HFO CCAM 22 days 6.7 
1 21 weeks US Asymptomatic CCAM 20 months Unkn
2 40 weeks US Distress, 100%
O2 hood
Unknown 2 days Unkn
3 32 weeks US Asymptomatic CCAM 4 months 2  1
US, ultrasound test; HFO, high frequency oscillation; CCAM, congenital cystic adenomatoInternational PPB registry (IPPBR) reported that, among 277
patients, nine (3.2%) had PPB in their family. Making a deﬁnitive
diagnosis of PPB is often difﬁcult because the differential diagnosis
of congenital lung lesions includes a wide spectrum of disorders,
such as CCAM, congenital peribronchial myoﬁbroblastic tumors
(CPMTs), congenital cystic adenomatoid or pulmonary airway
malformation (CCAM-CPAM) and other rare tumors, including
PPB. However, it is more difﬁcult to distinguish malignant tumors
from these lesions using prenatal imaging studies because the
features of the above-mentioned diseases are complex. In the
present case, the initial diagnosis was made as CCAM, and con-
servative therapy, including mechanical ventilation and the
administration of several antibiotics, was given as primary treat-
ment. Nevertheless, early surgical resection was fortunately per-
formed due to the patient’s persistent respiratory distress, which
revealed a large-sized tumor occupying the left thoracic cavity.
Early surgical resection should be considered in patients with
symptoms such as those observed in the present case, although
the management of asymptomatic cases remains controversial.
Careful evaluation and proper intervention are crucial in the
management for congenital lung lesions, which include rare
potentially malignant tumors, such as PPB. Complete surgical
resection is the most important treatment for PPB. Recently, some
authors have reported that postoperative adjuvant chemotherapy
and radiotherapy provide more favorable outcomes than surgical
resection alone, while other authors recommend the use of
adjuvant chemotherapy in all cases of PPB [8,9]. Moreover, the
effectiveness of radiation therapy after surgery for type II and III
disease is contended [10].
Thus far, four cases of PPB, including the present case, have
been diagnosed prenatally and treated with tumor resection
[11,12]. The average gestational age at diagnosis and birth among
these cases was 32.5 (21e40) and 38.5 (35e41) weeks, respec-
tively. All cases were detected with maternal ultrasonography.
Two patients had no respiratory symptoms at birth, whereas
respiratory distress was detected in the other two patients,
including the present patient. The initial diagnosis in three cases
was CCAM, while that of the other case was not described. Two
patients, including the present patient, with respiratory distress
underwent tumor resection in neonatal period, while the other
two cases underwent tumor resection at 20 and 4 months of age,
respectively. The pathological diagnosis in the three previously
reported cases was type I disease. On the other hand, the present
case was diagnosed as type II. Adjuvant chemotherapy was given
in the present case only, although another prenatally resected
patient suffered from local recurrence and was treated with
wedge tumor resection. No patients exhibited any metastatic
lesions and survived throughout their observation period
(Table 1). In the previous three cases, the pathological ﬁndings
were all of type I and the patients underwent surgical resection
at a relatively early age, including the neonatal period. These
factors are thought to be associated with favorable outcomes. The
present patient also demonstrated a favorable outcome despiteor size Pathological
type
Adjuvant
therapy
Observation
period
Recurrence Metastasis
6.3  3.4 cm Type II VAC 11 years None None
own Type I None 39 month None None
own Type I None 9 years Resection None
.5  0.3 cm Type I None 3 years None None
id malformation; VAC, vincristine, actinomycin D and cyclophosphamide.
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diagnosis made following the detection of the relatively large
tumor and the administration of post-operative adjuvant
chemotherapy may account for the favorable prognosis observed
in the present case. One interesting ﬁnding in this case is that the
patient was diagnosed with type II PPB during the prenatal
period, which indicates that some cases of type II PPB may
involve genetic abnormalities, such as DICER1 mutations rather
than characteristics of progression from type I to type II or III.
Further molecular biological investigations are needed to clarify
the morphogenesis of PPB. In conclusion, we herein reported a
rare case of PPB type II detected in the prenatal period. The
possibility of PPB should be taken into consideration in the dif-
ferential diagnosis of pediatric pulmonary disorders including
cystic lung diseases.
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